These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29527938)

  • 1. Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USA.
    Haque W; Verma V; Lewis GD; Lo SS; Butler EB; Teh BS
    Future Oncol; 2018 Apr; 14(9):819-827. PubMed ID: 29527938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
    Uhlig A; Uhlig J; Trojan L; Kim HS
    J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [German S3 guideline for renal cell carcinoma : Presentation and discussion of essential aspects for the radiation oncologist].
    Müller AC; van Oorschot B; Micke O; Guckenberger M
    Strahlenther Onkol; 2018 Jan; 194(1):1-8. PubMed ID: 28819766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.
    Singh AK; Winslow TB; Kermany MH; Goritz V; Heit L; Miller A; Hoffend NC; Stein LC; Kumaraswamy LK; Warren GW; Bshara W; Odunsi K; Matsuzaki J; Abrams SI; Schwaab T; Muhitch JB
    Clin Cancer Res; 2017 Sep; 23(17):5055-5065. PubMed ID: 28630212
    [No Abstract]   [Full Text] [Related]  

  • 5. Stereotactic body radiotherapy for renal cell cancer and pancreatic cancer : Literature review and practice recommendations of the DEGRO Working Group on Stereotactic Radiotherapy.
    Panje C; Andratschke N; Brunner TB; Niyazi M; Guckenberger M
    Strahlenther Onkol; 2016 Dec; 192(12):875-885. PubMed ID: 27778052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma.
    Miccio JA; Oladeru OT; Jun Ma S; Johung KL
    Urol Clin North Am; 2020 Aug; 47(3):399-411. PubMed ID: 32600541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
    Amini A; Altoos B; Bourlon MT; Bedrick E; Bhatia S; Kessler ER; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
    Pract Radiat Oncol; 2015; 5(6):e589-e596. PubMed ID: 26142027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
    Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
    J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
    Lanni TB; Grills IS; Kestin LL; Robertson JM
    Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal stereotactic body radiotherapy in the United States: A decade-long nationwide analysis of patient demographics, practice patterns, and trends over time.
    McClelland S; Kim E; Passias PG; Murphy JD; Attia A; Jaboin JJ
    J Clin Neurosci; 2017 Dec; 46():109-112. PubMed ID: 28864408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durable control of locally recurrent renal cell carcinoma using stereotactic body radiotherapy.
    Maclean J; Breau RH; Scheida N; Malone S
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25199199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.
    Correa RJM; Louie AV; Staehler M; Warner A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh BS; Lo SS; Muacevic A; Siva S
    J Urol; 2019 Jun; 201(6):1097-1104. PubMed ID: 30741849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case of the Month from the Peter MacCallum Cancer Centre, Melbourne, Australia: combination of stereotactic ablative body radiotherapy and radical nephrectomy for synchronous bilateral primary renal cell carcinoma.
    Ali M; Gaudreault M; Siva S
    BJU Int; 2023 May; 131(5):562-565. PubMed ID: 36716731
    [No Abstract]   [Full Text] [Related]  

  • 14. Long term control and preservation of renal function after multiple courses of stereotactic body radiation therapy for renal cell carcinoma.
    Reddy AV; Mills MN; Liauw SL; Baliga S; Kersh CR
    Can J Urol; 2019 Apr; 26(2):9743-9745. PubMed ID: 31012841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report.
    Onishi H; Kawasaki T; Zakoji H; Yoshida T; Komiyama T; Kuriyama K; Araya M; Saito R; Aoki S; Maehata Y; Tominaga L; Marino K; Watanabe I; Oguri M; Araki T; Enomoto N; Takeda M; Katoh R
    BMC Res Notes; 2014 Apr; 7():270. PubMed ID: 24767701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.
    Nanda RH; Liu Y; Gillespie TW; Mikell JL; Ramalingam SS; Fernandez FG; Curran WJ; Lipscomb J; Higgins KA
    Cancer; 2015 Dec; 121(23):4222-30. PubMed ID: 26348268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiation therapy for kidney cancer. Where do we stand?
    Sosa-Fajardo P; Blanco-Suarez JM; Pineda-Munguía Á; Rubí-Olea L; Peleteiro-Higuero P; Gajate P; Zafra-Martín J; Siva S; Bossi A; López-Campos F; Couñago F
    Int J Urol; 2023 May; 30(5):437-445. PubMed ID: 36746747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy.
    Miccio J; Johung K
    Oncology (Williston Park); 2019 May; 33(5):167-73, 177. PubMed ID: 31095714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study.
    Eminaga O; Akbarov I; Wille S; Engelmann U
    Int Urol Nephrol; 2015 Oct; 47(10):1653-63. PubMed ID: 26329746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Body Radiotherapy for a Rare Case of Sinonasal Metastasis Arising from Renal Cell Cancer.
    Cuccia F; Pastorello E; Vitale C; Figlia V; Levra NG; Mazzola R; Nicosia L; Ricchetti F; Rigo M; Ruggieri R; Alongi F
    In Vivo; 2023; 37(1):490-492. PubMed ID: 36593020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.